MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancer
=====================================================================================================================================

* Manu Prasad
* Jonathan Zorea
* Sankar Jagadeeshan
* Avital B Shnerb
* Sooraj Mathukkada
* Jebrane Bouaoud
* Lucas Michon
* Ofra Novoplansky
* Mai Badarni
* Limor Cohen
* Ksenia M Yegodayev
* Sapir Tzadok
* Barak Rotblat
* Libor Brezina
* Andreas Mock
* Andy Karabajakian
* Jérôme Fayette
* Idan Cohen
* Tomer Cooks
* Irit Allon
* Orr Dimitstein
* Benzion Joshua
* Dexin Kong
* Elena Voronov
* Maurizio Scaltriti
* Yaron Carmi
* Cristina Conde-Lopez
* Jochen Hess
* Ina Kurth
* Luc G T Morris
* Pierre Saintigny
* Moshe Elkabets